- Job seekers
- About UCB India
- Drug Safety
Keppra ® (Levetiracetam) is available as tablets, oral solution and as concentrate for solution for intravenous infusion.
Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy.
Keppra is indicated as adjunctive therapy:
Keppra solution for infusion is used as an adjunctive therapy in the treatment of partial onset of seizures in adults with epilepsy when oral administration is temporarily not feasible.